These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16030358)

  • 1. Identification of patients taking NSAIDs at high risk for GI bleeding.
    Harris J; Lee SB; Plowman BK; Morreale AP; Boggie DT; Delattre ML
    Am J Health Syst Pharm; 2005 Aug; 62(15):1543, 1548. PubMed ID: 16030358
    [No Abstract]   [Full Text] [Related]  

  • 2. Hospitalization for gastrointestinal bleeding associated with non-steroidal anti-inflammatory drugs among elderly patients using low-dose aspirin: a retrospective cohort study.
    Rahme E; Bardou M; Dasgupta K; Toubouti Y; Ghosn J; Barkun AN
    Rheumatology (Oxford); 2007 Feb; 46(2):265-72. PubMed ID: 16844699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study.
    Rahme E; Nedjar H
    Rheumatology (Oxford); 2007 Mar; 46(3):435-8. PubMed ID: 17255138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-trends in gastroprotection with nonsteroidal anti-inflammatory drugs (NSAIDs).
    Valkhoff VE; van Soest EM; Sturkenboom MC; Kuipers EJ
    Aliment Pharmacol Ther; 2010 Jun; 31(11):1218-28. PubMed ID: 20222917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal safety of nonsteroidal antiinflammatory drugs and selective cyclooxygenase-2 inhibitors in patients on warfarin.
    Cheetham TC; Levy G; Niu F; Bixler F
    Ann Pharmacother; 2009 Nov; 43(11):1765-73. PubMed ID: 19809010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and role of nonsteroidal antiinflammatory drugs in causing gastrointestinal bleeding.
    Lee I; Cryer B
    Gastrointest Endosc Clin N Am; 2011 Oct; 21(4):597-612. PubMed ID: 21944413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coxibs versus combination NSAID and PPI therapy for chronic pain: an exploration of the risks, benefits, and costs.
    Hur C; Chan AT; Tramontano AC; Gazelle GS
    Ann Pharmacother; 2006 Jun; 40(6):1052-63. PubMed ID: 16720709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Informatics. Detecting risks in elderly patients taking NSAIDs.
    Smith MA; Hampton C; Rodier L; Taylor A; Taylor-White C
    Nurse Pract; 2011 Apr; 36(4):51-3. PubMed ID: 21422979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study.
    Moride Y; Ducruet T; Boivin JF; Moore N; Perreault S; Zhao S
    Arthritis Res Ther; 2005; 7(2):R333-42. PubMed ID: 15743481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
    ;
    Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors.
    Battistella M; Mamdami MM; Juurlink DN; Rabeneck L; Laupacis A
    Arch Intern Med; 2005 Jan; 165(2):189-92. PubMed ID: 15668365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastroprotective strategies in chronic NSAID users: a cost-effectiveness analysis comparing single-tablet formulations with individual components.
    de Groot NL; Spiegel BM; van Haalen HG; de Wit NJ; Siersema PD; van Oijen MG
    Value Health; 2013; 16(5):769-77. PubMed ID: 23947970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimizing the risk of NSAID-induced GI bleeding.
    Hirschowitz BI
    Cleve Clin J Med; 1999 Oct; 66(9):524-7. PubMed ID: 10535177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in gastrointestinal bleeding in the Region of Valencia (2000-2005). Relationship to sales of nonsteroidal anti-inflammatory drugs and acid suppression medication.
    Peiró Moreno S; Cervera-Casino P; Sanfélix-Gimeno G; Librero López J
    Farm Hosp; 2011; 35(6):289-97. PubMed ID: 21481622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies to reduce the GI risks of antiplatelet therapy.
    Scheiman JM
    Rev Cardiovasc Med; 2005; 6 Suppl 4():S23-31. PubMed ID: 17710073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice.
    Moore RA; Derry S; Phillips CJ; McQuay HJ
    BMC Musculoskelet Disord; 2006 Oct; 7():79. PubMed ID: 17054784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Confounding adjustment via a semi-automated high-dimensional propensity score algorithm: an application to electronic medical records.
    Toh S; García Rodríguez LA; Hernán MA
    Pharmacoepidemiol Drug Saf; 2011 Aug; 20(8):849-57. PubMed ID: 21717528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced hospitalization cost for upper gastrointestinal events that occur among elderly veterans who are gastroprotected.
    Abraham NS; Hartman C; Hasche J
    Clin Gastroenterol Hepatol; 2010 Apr; 8(4):350-6; quiz e45. PubMed ID: 20096378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological and financial aspects of the use of non-steroidal anti-inflammatory analgesics.
    Paakkari H
    Pharmacol Toxicol; 1994; 75 Suppl 2():56-9. PubMed ID: 7816784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity.
    Conaghan PG
    Rheumatol Int; 2012 Jun; 32(6):1491-502. PubMed ID: 22193214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.